The use of interferon-α in the treatment of cutaneous melanoma: a review

    loading  Checking for direct PDF access through Ovid


During the past few years significant progress has been made in the treatment of cutaneous melanoma. These developments often involve the use of interferon-α (IFNα). Promising results have been reported in high risk patients using adjuvant treatment with high dose IFNα. A confirmatory trial of high dose IFNα and several adjuvant trials using low or intermediate dose IFNα are ongoing, and currently a standard regimen cannot be defined. High response rates have been reported in patients with metastatic disease with combination chemoimmunotherapy schedules. Randomized trials have to be performed in order to demonstrate a survival benefit over less toxic regimens. In this paper the current status of IFNα in the treatment of cutaneous melanoma is reviewed.

Related Topics

    loading  Loading Related Articles